The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Global Epidemiology of Tuberculosis
Open accessAbstract
Vision: A world free of TB Goal: To dramatically reduce the global burden of TB by 2015 in line with the Millennium Development Goals and the Stop TB Partnership targets Objectives: † Achieve universal access to high-quality diagnosis and patient-centered treatment † Reduce the human suffering and socioeconomic burden associated with TB † Protect poor and vulnerable populations from TB, TB/HIV, and multidrug-resistant TB † Support development of new tools and enable their timely and effective use Targets: † MDG 6, Target 8: . ..halted by 2015 and begun to reverse the incidence. ... † Targets linked to the MDGs and endorsed by the Stop TB Partnership: by 2005: detect at least 70% of new sputum smear-positive TB cases and cure at least 85% of these cases by 2015: reduce prevalence of and death due to TB by 50% relative to 1990 by 2050: eliminate TB as a public health problem (less than one case per million population) Components of the Stop TB Strategy 1. Pursue high-quality DOTS expansion and enhancement † Secure political commitment, with adequate and sustained financing † Ensure early case detection, and diagnosis through quality-assured bacteriology † Provide standardized treatment with supervision, and patient support † Ensure effective drug supply and management † Monitor and evaluate performance and impact 2. Address TB-HIV, MDR-TB, and the needs of poor and vulnerable populations † Scale-up collaborative TB/HIV activities † Scale-up prevention and management of multidrug-resistant TB (MDR-TB) † Address the needs of TB contacts, and of poor and vulnerable populations 3. Contribute to health system strengthening based on primary health care † Help improve health policies, human resource development, financing, supplies, service delivery, and information † Strengthen infection control in health services, other congregate settings, and households † Upgrade laboratory networks, and implement the Practical Approach to Lung Health (PAL) † Adapt successful approaches from other fields and sectors, and foster action on the social determinants of health 4. Engage all care providers † Involve all public, voluntary, corporate, and private providers through Public-Private Mix (PPM) approaches † Promote use of the International Standards for Tuberculosis Care (ISTC) Continued Global Epidemiology of TB
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,628
Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country
Dye, C., Scheele, S., >Dolin, P., Pathania, V., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project (1999) · JAMA · doi:10.1001/jama.282.7.677 · Cited by 2,947
Self-citationThe Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Self-citationThe Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Houben, R. M. G. J., & Dodd, P. J. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002152 · Cited by 2,054
Drivers of tuberculosis epidemics: The role of risk factors and social determinants
Lönnroth, K., Jaramillo, E., Williams, B. G., Dye, C., & Raviglione, M. (2009) · Social Science & Medicine · doi:10.1016/j.socscimed.2009.03.041 · Cited by 1,176
Self-citationSmall, P. M., Hopewell, P. C., Singh, S. P., Paz, A., Parsonnet, J., Ruston, D. C., Schecter, G. F., Daley, C. L., & Schoolnik, G. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406163302402 · Cited by 1,111
Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans
Comas, I., Coscolla, M., Luo, T., Borrell, S., Holt, K. E., Kato-Maeda, M., Parkhill, J., Malla, B., Berg, S., Thwaites, G., et al. (2013) · Nature Genetics · doi:10.1038/ng.2744 · Cited by 1,025
Daley, C. L., Small, P. M., Schecter, G. F., Schoolnik, G. K., McAdam, R. A., Jacobs, W. R., & Hopewell, P. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260404 · Cited by 986
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
Sterling, T. R., Villarino, M. E., Borisov, A. S., Shang, N., Gordin, F., Bliven-Sizemore, E., Hackman, J., Hamilton, C. D., Menzies, D., Kerrigan, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104875 · Cited by 977
Tuberculosis control and elimination 2010–50: cure, care, and social development
Lönnroth, K., Castro, K. G., Chakaya, J. M., Chauhan, L. S., Floyd, K., Glaziou, P., & Raviglione, M. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60483-7 · Cited by 899
Self-citationDrug development for neglected diseases: a deficient market and a public-health policy failure
Trouiller, P., Olliaro, P., Torreele, E., Orbinski, J., Laing, R., & Ford, N. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09096-7 · Cited by 893
The global tuberculosis situation and the new control strategy of the World Health Organization
Kochi, A. (1991) · Tubercle · doi:10.1016/0041-3879(91)90017-m · Cited by 843
Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997
Pablos-Méndez, A., Raviglione, M. C., Laszlo, A., Binkin, N., Rieder, H. L., Bustreo, F., Cohn, D. L., Lambregts-van Weezenbeek, C. S. B., Kim, S. J., Chaulet, P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382301 · Cited by 815
Self-citationGlobal Epidemiology of Tuberculosis: Morbidity and Mortality of a Worldwide Epidemic
Raviglione, M. C. (1995) · JAMA · doi:10.1001/jama.1995.03520270054031 · Cited by 811
Self-citationAlland, D., Kalkut, G. E., Moss, A. R., McAdam, R. A., Hahn, J. A., Bosworth, W., Drucker, E., & Bloom, B. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406163302403 · Cited by 799
Global tuberculosis incidence and mortality during 1990-2000.
Pj, D., Raviglione, M. C., & Kochi, A. (1994) · PubMed · Cited by 768
Self-citationTreatment of latent tuberculosis infection in HIV infected persons
Akolo, C., Adetifa, I., Shepperd, S., & Volmink, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000171.pub3 · Cited by 713
Anti-tuberculosis drug resistance in the world
Wilkinson, D. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90766-0 · Cited by 700
THE PROGNOSIS OF A POSITIVE TUBERCULIN REACTION IN CHILDHOOD AND ADOLESCENCE
COMSTOCK, G. W., LIVESAY, V. T., & WOOLPERT, S. F. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121593 · Cited by 698
Global Trends in Resistance to Antituberculosis Drugs
Espinal, M. A., Laszlo, A., Simonsen, L., Boulahbal, F., Kim, S. J., Reniero, A., Hoffner, S., Rieder, H. L., Binkin, N., Dye, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441706 · Cited by 671
Self-citationDoes progress towards universal health coverage improve population health?
Moreno-Serra, R., & Smith, P. C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61039-3 · Cited by 636
Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli
Velayati, A. A., Masjedi, M. R., Farnia, P., Tabarsi, P., Ghanavi, J., ZiaZarifi, A. H., & Hoffner, S. E. (2009) · Chest · doi:10.1378/chest.08-2427 · Cited by 607
Tiemersma, E. W., van der Werf, M. J., Borgdorff, M. W., Williams, B. G., & Nagelkerke, N. J. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017601 · Cited by 583
Worldwide Emergence of Extensively Drug-resistant Tuberculosis
Shah, N. S., Wright, A., Bai, G.-H., Barrera, L., Boulahbal, F., Martín-Casabona, N., Drobniewski, F., Gilpin, C., Havelková, M., Lepe, R., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1303.061400 · Cited by 583
Tuberculosis in developing countries: burden, intervention and cost.
Murray, C. J. L., Styblo, K., & Rouillon, A. (1990) · PubMed · Cited by 571
Badri, M., Wilson, D., & Wood, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08904-3 · Cited by 556
Tuberculosis: a global overview of the situation today.
Sudre, P., ten Dam, G., & Kochi, A. (1992) · Europe PMC (PubMed Central) · Cited by 539
Dye, C. (2005) · JAMA · doi:10.1001/jama.293.22.2767 · Cited by 534
Totally Drug-Resistant Tuberculosis in India
Udwadia, Z. F., Amale, R. A., Ajbani, K. K., & Rodrigues, C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir889 · Cited by 527
[Epidemiology of tuberculosis].
Neumann, G. (1971) · PubMed · Cited by 523
Hart, P. D., & Sutherland, I. (1977) · BMJ · doi:10.1136/bmj.2.6082.293 · Cited by 519
Espinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507
Self-citationHIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect Storm
Wells, C. D., Cegielski, J. P., Nelson, L. J., Laserson, K. F., Holtz, T. H., Finlay, A., Castro, K. G., & Weyer, K. (2007) · The Journal of Infectious Diseases · doi:10.1086/518665 · Cited by 483
Prospects for worldwide tuberculosis control under the WHO DOTS strategy
Dye, C., Garnett, G. P., Sleeman, K., & Williams, B. G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03199-7 · Cited by 462
EPIDEMIOLOGY OF TUBERCULOSIS IN THE UNITED STATES
RIEDER, H. L., CAUTHEN, G. M., COMSTOCK, G. W., & SNIDER, D. E. (1989) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036046 · Cited by 447
Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy.
Salo, W. L., Aufderheide, A. C., Buikstra, J., & Holcomb, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2091 · Cited by 435
Diacon, A. H., Dawson, R., von Groote-Bidlingmaier, F., Symons, G., Venter, A., Donald, P. R., van Niekerk, C., Everitt, D., Winter, H., Becker, P., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61080-0 · Cited by 435
Sonnenberg, P., Murray, J., Glynn, J. R., Shearer, S., Kambashi, B., & Godfrey-Faussett, P. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06712-5 · Cited by 433
International standards of tuberculosis care.
Mohan, A. (2006) · PubMed · Cited by 432
Prospects for Tuberculosis Elimination
Dye, C., Glaziou, P., Floyd, K., & Raviglione, M. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114431 · Cited by 402
Self-citationRaviglione, M. C., & Uplekar, M. W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68392-x · Cited by 398
Self-citationEpidemiology of Tuberculosis in the United States, 1985 Through 1992
Cantwell, M. F. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520070055038 · Cited by 367
Scaling up interventions to achieve global tuberculosis control: progress and new developments
Raviglione, M., Marais, B., Floyd, K., Lönnroth, K., Getahun, H., Migliori, G. B., Harries, A. D., Nunn, P., Lienhardt, C., Graham, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60727-2 · Cited by 340
Self-citationInternational Standards for Tuberculosis Care
Hopewell, P. C., Pai, M., Maher, D., Uplekar, M., & Raviglione, M. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70628-4 · Cited by 336
Self-citationHIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention
Narain, J. P., Raviglione, M. C., & Kochi, A. (1992) · Tubercle and Lung Disease · doi:10.1016/0962-8479(92)90033-g · Cited by 328
Self-citationLifetime Risks, Incubation Period, and Serial Interval of Tuberculosis
Vynnycky, E. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.3.247 · Cited by 322
Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis
Dye, C., Williams, B. G., Espinal, M. A., & Raviglione, M. C. (2002) · Science · doi:10.1126/science.1063814 · Cited by 314
Self-citationTuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa
Mukadi, Y. D., Maher, D., & Harries, A. (2001) · AIDS · doi:10.1097/00002030-200101260-00002 · Cited by 311
Global Epidemiology of Tuberculosis: Prospects for Control
Lönnroth, K., & Raviglione, M. (2008) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0028-1085700 · Cited by 298
Self-citationSurveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010
Zignol, M., van Gemert, W., Falzon, D., Sismanidis, C., Glaziou, P., Floyd, K., & Raviglione, M. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.11.092585 · Cited by 295
Self-citationMycobacterium tuberculosis Complex DNA from an Extinct Bison Dated 17,000 Years before the Present
Rothschild, B. M., Martin, L. D., Lev, G., Bercovier, H., Bar‐Gal, G. K., Greenblatt, C., Donoghue, H., Spigelman, M., & Brittain, D. (2001) · Clinical Infectious Diseases · doi:10.1086/321886 · Cited by 270
Worldwide Incidence of Multidrug‐Resistant Tuberculosis
Dye, C., Espinal, M. A., Watt, C. J., Mbiaga, C., & Williams, B. G. (2002) · The Journal of Infectious Diseases · doi:10.1086/339818 · Cited by 269
Evolution of WHO policies for tuberculosis control, 1948–2001
Raviglione, M., & Pio, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07880-7 · Cited by 264
Self-citationTuberculosis patients and practitioners in private clinics in India.
Uplekar, M., Juvekar, S. K., Morankar, S., et al. (1998) · PubMed · Cited by 263
Borgdorff, M. W., Nagelkerke, N. J. D., Dye, C., & Nunn, P. (2000) · PubMed · Cited by 261
Airborne Contagion and Air Hygiene
Phair, J. J. (1955) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.45.11.1495-c · Cited by 257
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
Weyer, K., Mirzayev, F., Migliori, G. B., Van Gemert, W., D'Ambrosio, L., Zignol, M., Floyd, K., Centis, R., Cirillo, D. M., Tortoli, E., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00157212 · Cited by 256
Self-citationSecular trends of tuberculosis in western Europe.
Raviglione, M. C., Sudre, P., Rieder, H. L., et al. (1993) · PubMed · Cited by 254
Self-citationGlobal tuberculosis control: lessons learnt and future prospects
Lienhardt, C., Glaziou, P., Uplekar, M., Lönnroth, K., Getahun, H., & Raviglione, M. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2797 · Cited by 250
Self-citationPrivate practitioners and public health: weak links in tuberculosis control
Uplekar, M., Pathania, V., & Raviglione, M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06076-7 · Cited by 243
Self-citationCriteria for the control of drug-resistant tuberculosis
Dye, C., & Williams, B. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140102797 · Cited by 233
First tuberculosis cases in Italy resistant to all tested drugs
Migliori, G. B., De Iaco, G., Besozzi, G., Centis, R., & Cirillo, D. M. (2007) · Weekly releases (1997–2007) · doi:10.2807/esw.12.20.03194-en · Cited by 219
Cock, K. M. D., & Chaisson, R. E. (1999) · PubMed · Cited by 214
The Global Plan to Stop TB, 2006-2015.
Raviglione, M. C. (2006) · PubMed · Cited by 213
Self-citationGuidelines for the Management of Drug-resistant Tuberculosis
Crofton, S. J., Chaulet, P., Maher, D., Grosset, J. H. E., Harris, W. T., Horne, N., Iseman, M. D., & Watt, B. (1997) · Cited by 210
Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries
Murray, C. J. L., DeJonghe, E., Chum, H. J., Nyangulu, D. S., Salomao, A., & Styblo, K. (1991) · The Lancet · doi:10.1016/0140-6736(91)92600-7 · Cited by 191
Assessment of worldwide tuberculosis control
Raviglione, M. C., Dye, C., Schmidt, S., & Kochi, A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04146-9 · Cited by 187
Self-citationO’Neill, K., Takane, M., Sheffel, A., Abou-Zahr, C., & Boerma, T. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.116798 · Cited by 182
The burden of HIV: insights from the Global Burden of Disease Study 2010
Ortblad, K. F., Lozano, R., & Murray, C. J. L. (2013) · AIDS · doi:10.1097/qad.0b013e328362ba67 · Cited by 182
Human Immunodeficiency Virus and the Prevalence of Undiagnosed Tuberculosis in African Gold Miners
Corbett, E. L., Charalambous, S., Moloi, V. M., Fielding, K., Grant, A. D., Dye, C., De Cock, K. M., Hayes, R. J., Williams, B. G., & Churchyard, G. J. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-590oc · Cited by 182
Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1
Harries, A. D., Hargreaves, N. J., Kemp, J., Jindani, A., Enarson, D. A., Maher, D., & Salaniponi, F. M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04639-0 · Cited by 181
GeneXpert—A Game-Changer for Tuberculosis Control?
Evans, C. A. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001064 · Cited by 172
Somma, D., Thomas, B. E., Karim, F., Kemp, J., Arias, N., Auer, C., Gosoniu, G. D., Abouihia, A., & Weiss, M. G. (2008) · PubMed · Cited by 171
Measuring tuberculosis burden, trends, and the impact of control programmes
Dye, C., Bassili, A., Bierrenbach, A., Broekmans, J., Chadha, V., Glaziou, P., Gopi, P., Hosseini, M., Kim, S., Manissero, D., et al. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70291-8 · Cited by 170
Self-citationSantoro-Lopes, G., Felix de Pinho, A. M., Harrison, L. H., & Schechter, M. (2002) · Clinical Infectious Diseases · doi:10.1086/338641 · Cited by 167
Lienhardt, C., Raviglione, M., Spigelman, M., Hafner, R., Jaramillo, E., Hoelscher, M., Zumla, A., & Gheuens, J. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis034 · Cited by 167
Self-citationSuárez, Floyd, Portocarrero, & Alarcon (2002) · The Lancet · Cited by 166
Girardi, E., Antonucci, G., Vanacore, P., Libanore, M., Errante, I., Matteelli, A., & Ippolito, G. (2000) · AIDS · doi:10.1097/00002030-200009080-00015 · Cited by 164
The seventh nationwide tuberculosis prevalence survey in Korea, 1995.
Hong, Y. P., Kim, S. J., Wj, L., Lee, E. K., & Han, Y. C. (1998) · PubMed · Cited by 162
Tuberculosis and HIV: current status in Africa.
Raviglione, M. C., Harries, A. D., Msiska, R., Wilkinson, D., & Nunn, P. (1997) · PubMed · Cited by 162
Self-citationThe Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
Meyer-Rath, G., Schnippel, K., Long, L., MacLeod, W., Sanne, I., Stevens, W., Pillay, S., Pillay, Y., & Rosen, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036966 · Cited by 158
The Dynamics of Tuberculosis in Response to 10 Years of Intensive Control Effort in Peru
Suarez, P. G., Watt, C. J., Alarcón, E., Portocarrero, J., Zavala, D., Canales, R., Luelmo, F., Espinal, M., & Dye, C. (2001) · The Journal of Infectious Diseases · doi:10.1086/322777 · Cited by 156
Ancient Egyptian prosthesis of the big toe
Nerlich, M. L., Zink, A., Szeimies, U., & Hagedorn, H. G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03507-8 · Cited by 147
Will tuberculosis become resistant to all antibiotics?
Dye, C., & Espinal, M. (2001) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2000.1328 · Cited by 141
Tuberculosis control in Europe and international migration
Rieder, H., Jp, Z., Raviglione, M. C., St, K., & Migliori, G. B. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07081545 · Cited by 140
Self-citationBorgdorff, M. W., Nagelkerke, N. J. D., van Soolingen, D., de Haas, P. E. W., Veen, J., & van Embden, J. D. A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009433 · Cited by 139
Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis.
Girardi, E., Raviglione, M. C., Antonucci, G., Godfrey‐Faussett, P., & Ippolito, G. (2000) · PubMed · Cited by 139
Self-citationHIV-associated tuberculosis in the era of highly active antiretroviral therapy.
Jones, J. L., Hanson, D. L., Ms, D., et al. (2000) · PubMed · Cited by 136
Responding to Market Failures in Tuberculosis Control
Gupta, R., Kim, J. Y., Espinal, M., Caudron, J.-M., Pécoul, B., Farmer, P. E., & Raviglione, M. C. (2001) · Science · doi:10.1126/science.1061861 · Cited by 136
Self-citationUse of genomics and combinatorial chemistry in the development of new antimycobacterial drugs
Barry, C. E., Slayden, R. A., Sampson, A. E., & Lee, R. E., Jr. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00253-1 · Cited by 136
Airborne infection : transmission and control
Riley, R. L., & O'Grady, F. (1961) · University of Michigan Library Repository · Cited by 123
Borgdorff, M. W., Šebek, M. M. G. G., Geskus, R. B., Kremer, K., Kalisvaart, N. A., & van Soolingen, D. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr058 · Cited by 111
Espinal, M., Pérez-Then, E. N., Baéz, J., Hénriquez, L., Fernández, K., Lopez, M. J., Olivo, P., & Reingold, A. L. (2000) · The Lancet · doi:10.1016/s0140-6736(99)04402-5 · Cited by 105
Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India
Floyd, K., Arora, V. K., Murthy, K. J. R., Lönnroth, K., Singla, N., Akbar, Y. H., Zignol, M., & Uplekar, M. W. (2006) · Bulletin of the World Health Organization · doi:10.2471/blt.05.024109 · Cited by 104
Self-citationAntiretroviral therapy for tuberculosis control in nine African countries
Williams, B. G., Granich, R., Cock, K. M. D., Glaziou, P., Sharma, A., & Dye, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005660107 · Cited by 100
Self-citationThe new Stop TB Strategy and the Global Plan to Stop TB 2006-2015
Raviglione, M. C. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.038513 · Cited by 99
Self-citationHayes, R., Halwiindi, B., Luo, N. P., Tembo, G., Pobee, J. O. M., Nunn, P. P., & McAdamt, K. P. W. J. (1993) · AIDS · doi:10.1097/00002030-199307000-00012 · Cited by 98
van Leth, F. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.06.037804 · Cited by 92
Grimwade, K., Sturm, A. W., Nunn, A., MBATHA, D. D., ZUNGU, D. D., & Gilks, C. F. (2005) · AIDS · doi:10.1097/00002030-200501280-00008 · Cited by 90
Evolution of human tuberculosis: A systematic review and meta-analysis of paleopathological evidence
Holloway‐Kew, K. L., Henneberg, R. J., Lopes, M. D. B., & Henneberg, M. (2011) · HOMO · doi:10.1016/j.jchb.2011.10.001 · Cited by 90
Botha, E., den Boon, S., Lawrence, K.-A., Reuter, H., Verver, S., Lombard, C. J., Dye, C., Enarson, D. A., & Beyers, N. (2008) · PubMed · Cited by 90
Assessing Tuberculosis Case Fatality Ratio: A Meta-Analysis
Straetemans, M., Glaziou, P., Bierrenbach, A. L., Sismanidis, C., & van der Werf, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020755 · Cited by 89
Self-citationProviding HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
Harries, A. D., Zachariah, R., & Lawn, S. D. (2009) · PubMed · Cited by 86
Low access to a highly effective therapy: a challenge for international tuberculosis control.
Dye, C., Watt, C. J., & Bleed, D. M. (2002) · PubMed · Cited by 86
New Diagnostics for Latent and Active Tuberculosis: State of the Art and Future Prospects
Pai, M., & O'Brien, R. (2008) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0028-1085707 · Cited by 85
Kenyon, T. A., Mwasekaga, M., Huebner, R. E., Rumisha, D., BINKIN, N. J., & Maganu, E. T. (1999) · PubMed · Cited by 85
Tuberculosis Preventive Therapy in the Era of HIV Infection: Overview and Research Priorities
Churchyard, G., Scano, F., Grant, A. D., & Chaisson, R. E. (2007) · The Journal of Infectious Diseases · doi:10.1086/518662 · Cited by 83
Grzybowski, S., Styblo, K., & Dorken, E. (1976) · Tubercle · doi:10.1016/0041-3879(76)90059-3 · Cited by 83
Glaziou, P., Floyd, K., Korenromp, E. L., Sismanidis, C., Bierrenbach, A. L., Williams, B. G., Atun, R. A., & Raviglione, M. C. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.087510 · Cited by 76
Self-citationPantoja, A., Floyd, K., Unnikrishnan, K. P., Jitendra, R., Padma, M. R., Lal, S., Uplekar, M., Chauhan, L. S., Kumar, P., Sahu, S. K., et al. (2009) · PubMed · Cited by 74
Self-citationPersonal and Societal Health Quality Lost to Tuberculosis
Miller, T. L., McNabb, S. J. N., Hilsenrath, P. E., Pasipanodya, J. G., & Weis, S. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005080 · Cited by 74
The measurement and estimation of tuberculosis mortality.
Korenromp, E. L., Bierrenbach, A. L., Williams, B. G., & Dye, C. (2009) · PubMed · Cited by 73
The resurgence of tuberculosis in Russia
Mv, S., & Dye, C. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.0895 · Cited by 73
(1999) · PubMed · Cited by 71
The Effect of Tuberculosis on Mortality in HIV Positive People: A Meta-Analysis
Straetemans, M., Bierrenbach, A. L., Nagelkerke, N., Glaziou, P., & van der Werf, M. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015241 · Cited by 68
Self-citationThe 1997 Nationwide Tuberculosis Prevalence Survey in the Philippines.
Tupasi, T. E., Radhakrishna, S., Rivera, A. B., et al. (1999) · PubMed · Cited by 65
HEST, N. A. H. V., Story, A., Grant, A. D., Antoine, D., Crofts, J., & Watson, J. M. (2008) · Epidemiology and Infection · doi:10.1017/s0950268808000496 · Cited by 56
Dye, C. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.3.558 · Cited by 55
Tuberculosis: vaccines in the pipeline
Ly, L. H., & McMurray, D. N. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.5.635 · Cited by 52
Klausner, J. D., Ryder, R. W., Baende, E., Lelo, U., Williame, J.-C., Ngamboli, K., Perriëns, J. H., Kaboto, M., & Prignot, J. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.1.106 · Cited by 48
Three-fold reduction in the prevalence of tuberculosis over 25 years in Indonesia.
Soemantri, S., Senewe, F. P., Tjandrarini, D. H., Day, R., Basri, C., Manissero, D., Mehta, F., & Dye, C. (2007) · PubMed · Cited by 38
Nicolau, I. A., Ling, D. I., Tian, L., Lienhardt, C., & Pai, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042479 · Cited by 37
Reflections on the white plague
Zumla, A. I., Mwaba, P., Huggett, J. F., Kapata, N., Chanda, D. M., & Grange, J. M. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70045-3 · Cited by 34
Diagnostic testing in the control of tuberculosis.
Perkins, M. D., & Kritski, A. L. (2002) · PubMed · Cited by 31
Squire, S. B., Obasi, A. I. N., & Simwaka, B. N. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68393-1 · Cited by 30
Survival Rates in Pulmonary Tuberculosis
Thompson, B. C. (1943) · BMJ · doi:10.1136/bmj.2.4326.721 · Cited by 28
Harries, A. D., Mbewe, L. N., Salaniponi, F. M. L., Nyangulu, D. S., Veen, J., Ringdal, T., & Nunn, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90874-0 · Cited by 27
Current Tuberculosis Vaccine Development
Young, D. (2000) · Clinical Infectious Diseases · doi:10.1086/313871 · Cited by 26
Present Trend of Case Fatality Rates in Tuberculosis.
Drolet, G. J. (1938) · American Review of Tuberculosis and Pulmonary Diseases · Cited by 26
Korenromp, E. L., Glaziou, P., Fitzpatrick, C., Floyd, K., Hosseini, M., Raviglione, M. C., Atun, R. A., & Williams, B. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038816 · Cited by 23
Self-citationBuhl, K., & Nyboe, J. (1967) · PubMed · Cited by 21
Update on the global epidemiology of tuberculosis.
Raviglione, M. C., & Luelmo, F. (1996) · PubMed · Cited by 21
Self-citationA sustainable agenda for tuberculosis control and research
Raviglione, M. C., Zumla, A. I., Marais, B. J., Horton, R. C., & Motsoaledi, A. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60373-0 · Cited by 20
Self-citationPerspective: Weigh all TB risks
Dye, C., & Raviglione, M. C. (2013) · Nature · doi:10.1038/502s13a · Cited by 11
Self-citation
Cited by
Iron and thiol redox signaling in cancer: an exquisite balance to escape ferroptosis
Toyokuni, S., Ito, F., Yamashita, K., Okazaki, Y., & Akatsuka, S. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.024 · Cited by 252
CSF in acute and chronic infectious diseases
(2018) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804279-3.00012-5 · Cited by 42
Metadata
- Authors
- Glaziou, P., Sismanidis, C., Floyd, K., & Raviglione, M.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2014-10-30
- Volume
- 5
- Issue
- 2
- Pages
- a017798-a017798
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2144416989
- Cited by
- 252
- References
- 138
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.